Novo Nordisk's new chair Lars Sorensen plans to add pharma expertise and address governance concerns after a major board overhaul backed by the company's foundation.

Newly-elected chairman of Wegovy-maker Novo Nordisk , Lars Rebien Sorensen, said on Friday he plans to enhance the board's ...

Pedersen and Maggie Fick COPENHAGEN/LONDON (Reuters) -Novo Nordisk faces a shareholder backlash on Friday as the Danish ...

Novo Nordisk experienced a major board reshuffle at a recent shareholder meeting, led by the Novo Nordisk Foundation. This ...

Shareholders will vote Friday on the appointment of Lars Rebien Sorensen as chair, Cees de Jong as vice chair, and Britt Meelby Jensen and Stephan Engels as board members. Current board members Kasim ...

The executive who brought Novo Nordisk A/S’s first weight-loss shot to market is coming back as chairman of the Danish ...

Shares in Novo Nordisk rose on Monday after the Wegovy maker lost out to Pfizer in a $10 billion bidding war for U.S. biotech ...

The drugmaker said it has started selling higher doses of the injectable treatment for $349 a month to patients paying the ...

Novo Nordisk faces board changes, investor friction and bold M&A moves as leadership pushes to regain momentum in the obesity ...

The Novo Foundation, through its subsidiary Novo Holdings, owns 25% of the shares and 70% of the votes in Novo Nordisk, making the election of its designees a likely formality when investors gather ...

The MarketWatch News Department was not involved in the creation of this content. The Novo Nordisk Foundation proposes new candidates for election as members of the Board of Directors of Novo Nordisk ...

Today, it was announced that Mikael Dolsten will not seek election to the Board of Directors at the upcoming extraordinary ...